6505--Notice of Intent to Award a Sole Source Procurement - Xofigo (Ra223)
Closed Special Notice Posted
- Solicitation number
- 36C25726Q0611
- Agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, issued a notice of intent to award a sole-source contract to Cardinal Health for 1,000 units of XOFIGO (Radium-223 dichloride) by June 8, 2026, with no requirement for full and open competition. Bayer Healthcare has designated Cardinal Health as the exclusive U.S. distributor for this radiopharmaceutical, and pricing will follow Bayer's established agreement. The VA invites all responsible sources to submit capability statements, proposals, or quotations within seven days of publication to demonstrate whether a comparable alternative source exists that would be more advantageous to the government. If no affirmative written response arrives by the deadline, the contract will be issued to Cardinal Health without further notice. The procurement is justified under 41 U.S.C. 3304(a)(1) and FAR 6.302-1 on the basis that only one responsible source can satisfy agency requirements. Contact Vance Farrell, Contract Specialist, at the contracting office in San Antonio, Texas.
Notice text
Presolicitation Notice Notice of Intent to Award a Sole Source Procurement
The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Cardinal Health for the procurement of the following item:
0001: XOFIGO® (Radium-223 dichloride), Unit of Issue: EA (uCi), Qty.: 1,000
The proposed sole source procurement will be made with a price agreement set by Bayer Healthcare.
Bayer Healthcare has designated Cardinal Health as their sole distributor for XOFIGO® in the United States.
This notice is not to be considered a request for quotations or proposals. No contract will be awarded based on offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 7 days from the publication of this notice, a contract or order will be issued to Cardinal Health without any further notice.
The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements.
Files
| File | Type | Posted |
|---|---|---|
| 36C25726Q0611.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Radiopharmaceuticals Base Plus Four Option Years VA San Diego Healthcare System | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS | Veterans Integrated Service Network 2 | No set-aside | |
| 6635--Dosimetry and Exposure Monitoring Services - VISN 1 BPA | Veterans Integrated Service Network 1 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity